Directed differentiation of periocular mesenchyme from human embryonic stem cells

Corneal tissue is the most transplanted of all body tissues. Currently, cadaveric donor tissues are used for transplantation. However, a global shortage of transplant grade material has prompted development of alternative, cell-based therapies for corneal diseases. Pluripotent stem cells are attract...

Full description

Saved in:
Bibliographic Details
Published inDifferentiation (London) Vol. 99; pp. 62 - 69
Main Authors Lovatt, Matthew, Yam, Gary Hin-Fai, Peh, Gary S., Colman, Alan, Dunn, N. Ray, Mehta, Jodhbir S.
Format Journal Article
LanguageEnglish
Published England Elsevier B.V 01.01.2018
Elsevier Science Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Corneal tissue is the most transplanted of all body tissues. Currently, cadaveric donor tissues are used for transplantation. However, a global shortage of transplant grade material has prompted development of alternative, cell-based therapies for corneal diseases. Pluripotent stem cells are attractive sources of cells for regenerative medicine, because large numbers of therapeutically useful cells can be generated. However, a detailed understanding of how to differentiate clinically relevant cell types from stem cells is fundamentally required. Periocular mesenchyme (POM), a subtype of cranial neural crest, is vital for development of multiple cell types in the cornea, including clinically relevant cells such as corneal endothelium and stromal keratocytes. Herein, we describe protocols for differentiation of POM from pluripotent stem cells. Using defined media containing inhibitors of TGFβ and WNT signalling, we generated neural crest cells that express high levels of the POM transcription factors PITX2 and FOXC1. Furthermore, we identified cells resembling POM in the adult cornea, located in a niche between the trabecular meshwork and peripheral endothelium. The generation and expansion of POM is an important step in the generation of a number of cells types that could prove to be clinically useful for a number of diseases of the cornea. •Differentiation of periocular mesenchmye from embyonic stem cells is presented.•Inhibition of TGFβ and WNT signalling drives differentiation.•The adult cornea contains periocular mesenchmye like cells.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0301-4681
1432-0436
DOI:10.1016/j.diff.2017.11.003